International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
2022 · Blood · 2,486 citations
https://doi.org/10.1182/blood.2022015850
D
Daniel A. Arber
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
445
Papers
33.5K
Citations
68
h-index
234
i10-index
Daniel A. Arber is an academic researcher from University of Illinois Chicago. The author has contributed to research in topics: Acute Myeloid Leukemia Research & Lymphoma Diagnosis and Treatment & Myeloproliferative Neoplasms: Diagnosis and Treatment. The author has an h-index of 68, co-authored 379 publications.
ORCID: 0000-0002-2160-9689Papers by this author
worksHematopoietic stem cell and progenitor cell mechanisms in myelodysplastic syndromes
2013 · Proceedings of the National Academy of Sciences · 281 citations
https://doi.org/10.1073/pnas.1222861110
Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults
2024 · New England Journal of Medicine · 183 citations
https://doi.org/10.1056/nejmoa2312948
<i>TP53</i> mutation defines a unique subgroup within complex karyotype de novo and therapy-related MDS/AML
2022 · Blood Advances · 175 citations
https://doi.org/10.1182/bloodadvances.2021006239
Effect of Prolonged Formalin Fixation on the Immunohistochemical Reactivity of Breast Markers
2002 · Applied immunohistochemistry & molecular morphology · 109 citations
https://doi.org/10.1097/00129039-200206000-00015
What have we learned about TP53-mutated acute myeloid leukemia?
2024 · Blood Cancer Journal · 43 citations
https://doi.org/10.1038/s41408-024-01186-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat